TP53 and lung adenocarcinoma: The two subtypes also differed significantly in their mutational profiles, with the particular high-scoring subgroup having significant mutations in the oncogene TP53, aligning with prior research indicating a correlation between TP53 mutations and invasive lung adenocarcinomas, and that elevated TP53 mutations typically signal the development of invasion (Zhang et al., 2019).